Production of recombinant allergens in plants
β Scribed by Georg Schmidt; Gabriele Gadermaier; Heidi Pertl; Marc Siegert; Kirsi-Marja Oksman-Caldentey; Anneli Ritala; Martin Himly; Gerhard Obermeyer; Fatima Ferreira
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 222 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1568-7767
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
This review is based on our recent experience in producing the first commercial recombinant proteins in transgenic plants. We bring forward the issues that have to be considered in the process of selecting and developing a winning transgenic plant production system. From the production point of view
## Abstract Global demand for recombinant proteins has steadily accelerated for the last 20 years. These recombinant proteins have a wide range of important applications, including vaccines and therapeutics for human and animal health, industrial enzymes, new materials and components of novel nanoβ
A considerable number of cDNAs coding for allergens have been isolated and expressed. Structural and immunological similarities between recombinant allergens and natural allergens indicate that a sufficient panel of recombinant allergens can be produced for diagnosis and therapy of allergic diseases